JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the release of a preliminary pricing supplement for its Market Linked Securities. These securities are callable with contingent coupon payments, linked to the performance of the Nasdaq-100 Index, the Russell 2000 Index, and the S&P 500 Index, and are due on March 1, 2027. The securities are designed to pay a contingent coupon if the closing level of the lowest performing index on each eligible trading day is above a specified threshold. The securities may not pay fixed interest and the principal repayment is contingent on index performance. JPMorgan may redeem the securities early, and investors may lose some or all of their principal if the index performs...Show More

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the release of a preliminary pricing supplement for its Market Linked Securities. These securities are callable with contingent coupon payments, linked to the performance of the Nasdaq-100 Index, the Russell 2000 Index, and the S&P 500 Index, and are due on March 1, 2027. The securities are designed to pay a contingent coupon if the closing level of the lowest performing index on each eligible trading day is above a specified threshold. The securities may not pay fixed interest and the principal repayment is contingent on index performance. JPMorgan may redeem the securities early, and investors may lose some or all of their principal if the index performs poorly. The securities are unsecured and unsubordinated obligations of JPMorgan Financial, guaranteed by JPMorgan Chase & Co., and are subject to the credit risk of both entities. The securities are not bank deposits, are not FDIC insured, and are not guaranteed by a bank. The pricing date is set for August 30, 2024, with an issue date of September 5, 2024. The announcement details the risks, including market and credit risks, and the lack of an exchange listing, suggesting they are designed to be held to maturity. The SEC has not approved or disapproved the securities, nor have they passed upon the accuracy or adequacy of the pricing supplement.